
Navreet Kaur
About Navreet Kaur
Data last updated:
Navreet Kaur is a Director at Esemite Lifesciences Private Limited (since 2024) and Additional Director at Candor Lifesciences Limited (since 2025). The companies operate in Food And Beverages and Pharma. The largest current company by reported revenue is Esemite Lifesciences Private Limited at ₹2.56 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Jan 2024 | 2022 | ₹2.56 Cr (FY 2025) | Active | |
| Additional Director | 01 Nov 2025 | 2021 | Active |
Board colleagues of Navreet Kaur
| Name | DIN | Company | Designation |
|---|---|---|---|
| Harsimran Kaur | 09368566 | Esemite Lifesciences Private Limited , Candor Lifesciences Limited | Director |
| Amarjit Singh | 00509040 | Candor Lifesciences Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Navreet Kaur
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Navreet Kaur
Navreet Kaur currently holds 2 directorships: Esemite Lifesciences Private Limited (Director, since 22 Jan 2024, revenue ₹2.56 Cr (FY 2025)); Candor Lifesciences Limited (Additional Director, since 01 Nov 2025).
Navreet Kaur was first appointed on 22 Jan 2024 as Director at Esemite Lifesciences Private Limited. The most recent appointment on record is 01 Nov 2025 at Candor Lifesciences Limited.
The current boards of Navreet Kaur's companies include Harsimran Kaur (Esemite Lifesciences Private Limited), Amarjit Singh (Candor Lifesciences Limited).